RM
Reagan Micheal Jarvis
Ceo - Chief Executive Officer at Anocca
View Reagan's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Ceo - Chief Executive Officer
Present
Company Details
51-200 Employees
Anocca understands the complexity of T-cell biology. We have established a unique technology platform that replicates functional human cellular immunobiology and unlocks the potential of T-cell immunotherapies and vaccine strategies that leverage T-cell immunity. Anocca’s approach and proprietary technologies deliver the means to efficiently and precisely harness and manipulate T-cell immunity, enabling a range of next-generation therapies and vaccination strategies that address unmet patient need in oncology, infectious disease and autoimmunity. Today Anocca has a focus on delivering T-cell receptor-modified T-cell therapies (TCR-T) in oncology. Anocca is rapidly progressing a pipeline of novel therapeutic TCR-T candidates generated entirely with our own technologies towards clinical trials utilising our in-house state-of-the-art manufacturing capabilities and processes.
Year Founded
2014
Social Media
Linkedin
Industry
Biotechnology Research, Biotechnology research and development, Research and testing, IT, Internet, R&D, Chemistry, physics and biological engineering consultants, Technical offices and engineering consultancies, architects
HQ Location
Forskargatan 20C B229 Södertälje, 15136, SE
Keywords
BiotechnologyImmunotherapeuticsDrug DiscoveryDrug DevelopmentImmunologyImmunotechnologyImmuno-Oncology
Discover More About Cleveland Clinic

Find verified contacts of Reagan Micheal Jarvis in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.